Liv Jonsson

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. ncbi High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
    Liv Jonsson
    Department of Clinical Sciences, Pathology, Lund University, Skane University Hospital, 221 85 Lund, Sweden
    Diagn Pathol 6:91. 2011
  2. ncbi High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
    Björn Nodin
    Department of Clinical Sciences, Division of Pathology, Lund University, Skane University Hospital, 221 85, Lund, Sweden
    Diagn Pathol 7:82. 2012
  3. ncbi Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study
    Liv Jonsson
    Department of Clinical Sciences, Pathology, Lund University, Skane University Hospital, 221 85 Lund, Sweden
    J Transl Med 9:114. 2011
  4. ncbi Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study
    Marie Fridberg
    Department of Clinical Sciences, Division of Pathology, Lund University, Skane University Hospital, 221 85 Lund, Sweden
    Biol Sex Differ 3:16. 2012

Collaborators

Detail Information

Publications4

  1. ncbi High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
    Liv Jonsson
    Department of Clinical Sciences, Pathology, Lund University, Skane University Hospital, 221 85 Lund, Sweden
    Diagn Pathol 6:91. 2011
    ..The aim of this study was to examine the prognostic impact of immunohistochemical RBM3 expression in prostate cancer...
  2. ncbi High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
    Björn Nodin
    Department of Clinical Sciences, Division of Pathology, Lund University, Skane University Hospital, 221 85, Lund, Sweden
    Diagn Pathol 7:82. 2012
    ..The aim of the present study was to examine the associations of MCM3 expression with clinical outcome and RBM3 expression in a prospective, population-based cohort of melanoma...
  3. ncbi Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study
    Liv Jonsson
    Department of Clinical Sciences, Pathology, Lund University, Skane University Hospital, 221 85 Lund, Sweden
    J Transl Med 9:114. 2011
    ..In this study, the prognostic value of immunohistochemical RBM3 expression was assessed in incident cases of malignant melanoma from a prospective population-based cohort study...
  4. ncbi Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study
    Marie Fridberg
    Department of Clinical Sciences, Division of Pathology, Lund University, Skane University Hospital, 221 85 Lund, Sweden
    Biol Sex Differ 3:16. 2012
    ..abstract:..